Introduced in Senate text (IS) · Kelly / Capito / Blackburn / Cortez Masto / Klobuchar · referred to Senate Judiciary on February 27, 2025
HIDTA Enhancement Act (S. 767)
Registered context series — forecast regardless of this bill
These series are tracked because the bill made them worth watching. They are not resolutions of any bill metric; each entry states what the series is not.
FY2026 HIDTA AL 95.001 obligations
For FY2026, what will the USAspending API v2 advanced search spending_over_time endpoint return on the first registered-query snapshot for results[time_period.fiscal_year=2026].aggregated_amount, scaled to usd_millions, for prime financial-assistance award transactions filtered to Assistance Listing 95.001, grouped by action-date federal fiscal year, not seasonally adjusted?
The whole Assistance Listing 95.001 award-transaction aggregate. Not section 707(s) supplemental competitive grants or spending under a newly permitted purpose; not all HIDTA financial-account obligations, outlays, appropriations, budget authority, or authorization; and no spending is attributed to S. 767.
Provisions
Section 2(1) and 2(2)(A) — Annual assessments and reports
1. §2(1), §2(2)(A): fentanyl reporting and disclosure of HIDTA limitations
Section 2(1) and 2(2)(A) — Annual assessments and reports
1. §2(1), §2(2)(A): fentanyl reporting and disclosure of HIDTA limitations
Section 2(1) adds §706(g)(3)(E) to the Director's existing annual assessment. The new element would describe prior-calendar-year use of HIDTA funds for fentanyl-trafficking investigations, any resulting prosecution, amounts of covered substances “seized by a HIDTA-funded initiative in the area,” and law-enforcement and predictive data from regional threat assessments. The text does not clearly define “the area” or require disaggregation by initiative or HIDTA. Section 2(2)(A) separately adds §707(l)(2)(H) to the annual HIDTA task-force assessment, requiring disclosure of limitations on an area's ability to meet its purposes or goals and recommendations involving resources, partnerships, authority, or law. These clauses mandate reporting, not new investigative conduct, adoption of recommendations, a standardized public dataset, or improvement in fentanyl outcomes.
Quoted from the bill ▸
“a report describing the use of HIDTA funds to investigate organizations and individuals trafficking in fentanyl or fentanyl-related substances, including any resulting prosecution, in the prior calendar year” … “any limitations of the ability of a high intensity drug trafficking area to meet the purpose or goals of the area and recommendations to address any such limitations”.
Countersignable goals
Likely effects — shown regardless of the goals
Fentanyl-specific reporting scope
The annual assessment would have to add a prior-calendar-year account of HIDTA-funded fentanyl investigations, any resulting prosecution, seizure amounts using the clause's undefined “in the area” formulation, and regional pattern and trend data.
Diagnostic disclosure
The annual task-force assessment would have to identify barriers to each area's stated purposes or goals and recommend possible responses, but no recipient would have to adopt those recommendations.
Ambiguous enforcement-output signal
A higher reported seizure amount can reflect greater enforcement activity, greater underlying supply, changes in initiative coverage, different units, or reporting revisions; it does not by itself establish less trafficking or harm.
Timing and comparability burden
The new clause asks for prior-calendar-year information inside an existing assessment framework, while investigative and seizure results may not be final in time for the first annual publication and may not be comparable across areas.
Implementation barriers
HIDTA initiatives and ONDCP data stewards
They would need consistent definitions for a HIDTA-funded initiative and a resulting prosecution, rules for joint-seizure attribution and deduplication, separate treatment of weight and dosage units, and a policy for provisional or revised values.
Regional HIDTAs and law-enforcement partners
They would have to convert sensitive investigative, predictive, sealed-case, and threat-assessment material into reportable information without compromising operations or overstating what the underlying data can predict.
Congress and public evaluators
The bill does not prescribe a public venue, machine-readable format, common denominator, first-release rule, or method for judging whether a limitation or recommendation is complete and candid.
Candidate outcome metrics
The relevant annual Federal assessment, audited for every element named in §706(g)(3)(E): use of HIDTA funds in covered investigations, any resulting prosecution, the seizure-amount content described as substances “seized by a HIDTA-funded initiative in the area,” and regional law-enforcement and predictive trend data. The audit must not assume a row for each initiative or area; this is a document-compliance check rather than a stable numeric series, and the bill does not guarantee a public machine-readable release.
ONDCP's annual HIDTA Report to Congress table for quantities of drugs removed from the marketplace by HIDTA initiatives: reported fentanyl quantity, preserving weight and dosage-unit measures separately and recording the release vintage and any revision status. This is a recurring official enforcement output, but it is delayed, potentially revisable, and not a causal measure of reduced supply or harm.
The annual §707(l)(2) assessment, audited for identified limitations on each HIDTA's ability to meet its purposes or goals and corresponding recommendations involving resources, partnerships, authority, or law. Publication alone does not show that the recommendation was adopted or effective, and qualitative adequacy is not a mechanically resolvable series.
Conditional forecast sketches
P(the annual assessment covering calendar year t contains every element named in §706(g)(3)(E) | the reporting amendment is enacted versus not enacted). This is a document-content conditional; absence cannot resolve mechanically unless the controlling assessment is publicly available.
P(the annual §707(l)(2) assessment identifies HIDTA limitations and corresponding recommendations | the limitations amendment is enacted versus not enacted). The bill supplies no quantitative completeness standard or required public format.
P(ONDCP-reported HIDTA fentanyl quantity removed in calendar year t, with weight and dosage units kept separate | S. 767 enacted versus not enacted). The level is a forecastable official output candidate, not an identified causal effect on trafficking or harm.
Section 2(2)(B)–(C) — Authorization and supplemental grants
2. §2(2)(B)–(C): $333 million annual authorization and expanded fentanyl-grant authority
Section 2(2)(B)–(C) — Authorization and supplemental grants
2. §2(2)(B)–(C): $333 million annual authorization and expanded fentanyl-grant authority
Section 2(2)(B) authorizes $333 million for the HIDTA program in each of fiscal years 2025 through 2030. Section 2(2)(C) raises the §707(s) ceiling on supplemental competitive grants from $10 million to $14.224 million and expands allowable purposes to cover investigation and interdiction assistance involving fentanyl and other substances plus any additional Director-determined purpose appropriate to enhance fentanyl prevention, seizure, or interdiction. The authorization does not appropriate money, and the higher supplemental-grant ceiling neither adds to the total appropriation nor requires the Director to use the full amount or select any particular new purpose.
Quoted from the bill ▸
“$333,000,000 for each of fiscal years 2025 through 2030.” Section 2 also amends subsection (s) “by striking $10,000,000 and inserting $14,224,000” and adds “providing assistance to Federal, State, local, and Tribal law enforcement agencies in investigations and activities related to the interdiction of fentanyl and other substances”.
Countersignable goals
Likely effects — shown regardless of the goals
Authorization rather than appropriation
The $333 million amount can guide later appropriations, but enactment alone would not provide budget authority, guarantee annual funding at that level, create an obligation, or produce an outlay.
Larger ceiling within finite funds
The Director could devote up to $4.224 million more of an otherwise appropriated HIDTA amount to supplemental grants, potentially increasing those awards while reducing funds available for other HIDTA uses if the total appropriation does not rise.
Broader eligible purposes
Supplemental grants could support specified intergovernmental investigation and interdiction assistance or other Director-selected fentanyl purposes, increasing flexibility while reducing ex ante specificity about recipients and activities.
Partly elapsed authorization window
Fiscal year 2025 has ended and fiscal year 2026 is nearly complete as of the analysis date, so later enactment cannot by itself recreate appropriations, awards, obligations, or activities for elapsed periods.
Implementation barriers
Congress and the appropriations process
Annual appropriations must separately provide budget authority, and the bill contains no transition rule explaining how its FY2025 or late-FY2026 authorization should operate if enacted after those periods.
ONDCP and HIDTA grant administrators
They would need award criteria, eligible-cost rules, purpose coding, recipient oversight, and a method for using the larger ceiling alongside existing supplemental-grant purposes and finite program funds.
Public evaluators
The bill requires no recurring public table that separates authorization, appropriation, award, obligation, outlay, and dollars used under each newly added purpose.
Candidate outcome metrics
Annual enacted HIDTA budget authority in appropriations law and official ONDCP budget materials for fiscal years 2025 through 2030, compared with but not equated to the $333 million authorization. Appropriations and any separately reported obligations are distinct observations, and no exact Thesis registry concept was verified for this path.
Official ONDCP award and obligation records for §707(s) supplemental grants, including total dollars, recipients, and amounts tagged to the new investigation, interdiction, prevention, or other Director-determined purposes. The ceiling and eligibility expansion do not guarantee use, and the bill creates no required public purpose-level field or recurring table.
Conditional forecast sketches
P(enacted annual HIDTA budget authority in fiscal years 2027 through 2030 | the $333 million authorization is in effect versus not in effect). The authorization is neither a spending target nor a funding guarantee, and elapsed fiscal years are excluded from this sketch.
Section 2(2)(D) — Additional prosecutorial resources
3. §2(2)(D): qualified prosecutorial resources and a 180-day AUSA request process
Section 2(2)(D) — Additional prosecutorial resources
3. §2(2)(D): qualified prosecutorial resources and a 180-day AUSA request process
New §707(t)(1) would direct the Attorney General to make sufficient investigative and prosecution resources available as practicable, including temporary reassignment under existing §707(b)(2) during fiscal years 2024 through 2030. A reassigned assistant United States attorney would prioritize investigations and prosecutions of organizations and individuals trafficking in fentanyl or fentanyl-related substances, and the Attorney General could extend a reassignment as necessary to finish ongoing work. New §707(t)(2) would require the Attorney General to establish, within 180 days after enactment, a process through which the ONDCP Director, after consulting each designated area's Executive Board, may request a temporary AUSA. Establishing the process is mandatory; making, approving, or filling a request is not, and the bill supplies no staffing floor or public-reporting duty.
Quoted from the bill ▸
“The Attorney General shall make available sufficient investigative and prosecution resources as may be practicable” and “Not later than 180 days after the date of enactment of this subsection, the Attorney General shall establish a process” under which the Director may request a temporary reassignment.
Countersignable goals
Likely effects — shown regardless of the goals
Mandatory process, discretionary use
The Attorney General would have to establish the request process on an enactment-relative deadline, but the Director could decline to request an AUSA and the Attorney General or employing agency could decline or be unable to effect a reassignment.
Qualified resource direction
The phrases “sufficient” and “as may be practicable” express a resource priority without a numeric staffing minimum, response deadline, approval criterion, or required number of assignments.
Case-priority and opportunity-cost shift
A reassigned AUSA would prioritize covered fentanyl-trafficking matters during the assignment, potentially adding capacity in a HIDTA while shifting attention from other cases or districts.
Continuation beyond the nominal window
The Attorney General could extend a temporary assignment long enough to conclude ongoing work, so case continuity could outlast fiscal year 2030 even though fiscal year 2024 already preceded the bill's introduction.
Implementation barriers
Attorney General, ONDCP Director, and HIDTA Executive Boards
They would need to define consultation, request contents, prioritization, review criteria, timing, records, and responsibility for a process that the bill does not require them to publish.
United States Attorneys' Offices and employing agencies
Reassignments depend on available attorneys, approvals, district needs, conflicts, clearances, travel or relocation, case handoffs, and funding that the bill does not quantify.
Public evaluators
Personnel actions and ongoing cases can be confidential, and general Federal drug-case statistics do not identify a HIDTA request, a temporary reassignment, or prosecutions caused by the added process.
Candidate outcome metrics
An official Department of Justice directive, policy, or other authoritative record establishing the §707(t)(2) request process, dated against the 180-day enactment clock and audited for Director requests after Executive Board consultation. The bill does not require public notice, so absence of public evidence cannot by itself establish noncompliance.
Department of Justice administrative counts of HIDTA consultations and AUSA requests, approvals, assignment starts, full-time-equivalent effort, durations, extensions, and covered districts. These fields would show whether the process supplied capacity, but the bill mandates no public recurring dataset and general staffing or prosecution totals cannot isolate the mechanism.
Conditional forecast sketches
P(authoritative public evidence shows that the Attorney General established the §707(t)(2) request process by E + 180 days | S. 767 enacted on date E). This is a one-sided implementation conditional; non-enactment produces no process duty, and the bill's failure to require publication prevents a missing public record from resolving to failure.